Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

5-alpha reductase inhibitors do not increase hip fracture risk.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Male pattern baldness does not cause an increased risk of prostate cancer.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

AGA affects many, progresses differently, and early treatment is crucial.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Using finasteride with TIP extends time off period for prostate cancer patients.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.